Virtus Biotech ETF (BBP): ETF
ETF traded on ARCX under symbol BBP. Quoted in usd.
Virtus Biotech ETF
+2.16%$104.53
ARCX:BBPSector Equity
AUM $130.95M·YTD --·Yield --
ARCX:BBP$104.53+2.16%AUM $130.95MAbout BBP
The Virtus Biotech ETF seeks to replicate the overall financial performance, encompassing both price appreciation and income generation, of the LifeSci Biotechnology Products Index, prior to any deductions for fees and expenses. This index specifically comprises biotechnology companies that have received approval from the FDA for at least one drug therapy. Furthermore, the fund underwent a name change on February 27, transitioning from Virtus LifeSci Biotech Products ETF to its current designation.
Largest holdings
- MRNA Moderna Inc6.70%
- XERS Xeris Biopharma Holdings Inc2.95%
- VSTM Verastem Inc2.70%
- IOVA Iovance Biotherapeutics Inc2.59%
- OMER Omeros Corp2.55%
- KNSA Kiniksa Pharmaceuticals International Plc2.38%
- ADMA ADMA Biologics Inc2.04%
- BGNE BeOne Medicines Ltd2.03%
- ZLAB Zai Lab Ltd1.96%
- HALO Halozyme Therapeutics Inc1.96%
Dividend History
Benchmark Comparison
Compared against
Performance Returns
Drawdown Chart
Analyst Coverage
Savings Plan Calculator
Total Invested
$70,000
Final Portfolio
$111,217
Total Return
+$41,217
(+58.9%)
Dividends Reinvested
$0
compounded into portfolio
Defaults are seeded from historical performance and trailing twelve-month yield. Past performance is not a forecast. Feel free to adjust any input to model your own assumptions.
ETF Key Metrics
AUM$130.95M
NAV$100.73
Premium/Discount+3.77%
Expense Ratio0.34%
Market Cap--
Shares Outstanding--
Inception DateDec. 16, 2014
Fund Details
IssuerVirtus
Asset ClassSector Equity
Beta--
SectorFinancial Services
DomicileUS
52-Week Range
$73.55$110.05
Current: $104.53
Volume
Volume19.85K
Avg Volume11.75K
Vol/Avg1.69x
30d
12.65K
60d
14.20K
90d
12.47K
Comparable ETFs